核素心肌显像在冠状动脉旁路移植术中的应用

张佳胤

张佳胤

文章导航 > 国际放射医学核医学杂志 > 2005, 29 > 4: (152-154)

引用本文:

Citation:

核素心肌显像在冠状动脉旁路移植术中的应用

张佳胤

200025 上海, 上海第二医科大学瑞金医院核医学科
中图分类号: R817.4

Application of nuclear myocardial imaging in coronary artery bypass graft

ZHANG Jia-yin

Department of Nuclear Medicine, The Third Hospital Affiliated to Suzhou University, Changzhou 213003, China
CLC number: R817.4

摘要: 心肌存活的判断对于严重冠心病患者选择再血管化适应证、估测疗效和判断预后有着极其重要的临床意义。传统的²⁰¹Tl静息-再分布显像能较好又经济地评估心肌活力,门控显像技术显示的室壁运动情况能帮助医师更准确地判断缺血心肌的活力,¹⁸F-氟代脱氧葡萄糖(¹⁸F-FDG)心肌代谢显像是迄今评估心肌活力最准确的方法。患者在冠状动脉旁路移植术后出现胸闷症状时,核素心肌显像也能准确地判断有无新发缺血灶或是原有病变术后再狭窄。
- 存活心肌 /
- 核素显像 /
- 冠状动脉旁路移植术 /
- 冠心病
Abstract: The assessment of myocardial viability is clinically significant for doctors in determining which patient to undergo coronary artery bypass graft (CABG), and pridicting the sugery effect and prognosis as well. ²⁰¹T1 rest/redistribution imaging can effectively and economically assess the myocardial viability, The gated SPECT imaging can provide the motion information of the myocardium which enhance the sensitivity and specificity in evaluating the myocardial viability in some equivocal cases. ¹⁸F-FDG myocardial metabolic imaging combined with myocardial perfusion imaging still remain as the "Golden Standard" in assessing the myocardial viability. Besides, myocardial perfusion imaging can effectively distinguish the re-stenosis from new coronary arterial stenosis in post-CABG patients with angina symptoms.
- myocardial viability /
- positron emission tomography /
- coronary artery bypass graft /
- coronary artery disease
本作品遵循Signature-Non-Commercial Use 4.0 International (CC BY-NC 4.0)协议

[1]	周前.中华影像医学,影像核医学卷[M].北京:人民卫生出版社,2002.71-72.
[2]	Bonow RO, Dilsizian V, Cuocolo A, et al. Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction. Comparison of thallium scintigraphy with reinjection and PET imaging with ¹⁸F-Fluorodeoxyglucose[J]. Circulation, 1991, 83(1):26-37.
[3]	Pirich C, Schwaiger M. The clinical role of positron emission tomography in management of the cardiac patient[J]. Rev Port Cardiol,2000, 19(Suppl 1):89-100.
[4]	Barrington SF, Chambers J, Hallett WA, et al. Comparison of sestamibi, thallium, echocardiography and PET for the detection of hibernating myocardium[J]. Eur J Nucl Med Mol Imaging, 2004, 31(3):355-361.
[5]	Sloof GW, Knapp FF Jr, van Lingen A, et al. Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography[J]. Nucl Med Commun, 2003, 24(4):375-381.
[6]	Schmidt M, Voth E, Schneider CA, et al. F-18-FDG uptake is a reliable predictory of functional recovery of akinetic but viable infarct regions as defined by magnetic resonance imaging before and after revascularization[J]. Magn Reson Imaging, 2004, 22(2):229-236.
[7]	李殿富.核素显像识别存活心肌的临床应用进展[J].国外医学·放射医学核医学分册,2003,27(3):104-106.
[8]	Liao L, Cabell CH, Jollis JG, et al. Usefulness of myocardial viability or ischemia in predicting long-term survival for patients with severe left ventricular dysfunction undergoing revascularization[J].Am J Cardiol, 2004, 93(10):1275-1279.
[9]	Mabuchi M, Kubo N, Morita K, et al. Prediction of functional recovery after coronary bypass surgery using quantitative gated myocardial perfusion SPECT[J]. Nucl Med Commun, 2003, 24(6):625-631.
[10]	Blinder G, Benhorin J, Koukoui D, et al. The value of electrocardiography-gated multi-slice computed tomography in the evaluation of patients with chest pain [J]. Isr Med Assoc J, 2005, 7(7):419-423.
[11]	Schlosser T, Konorza T, Hunold P, et al. Noninvasive visualization of coronary artery bypass grafts using 16-detector row computed tomography[J]. J Am Coll Cardiol, 2004, 44(6):1224-1229.
[12]	Fayad ZA. MR imaging for the noninvasive assessment of atherothrombotic plaques[J]. Magn Reson Imaging Clin N Am, 2003, 11(1): 101-113.
[13]	Watanuki A, Yoshino H, Udagawa H, et al. Quantitative evaluation of coronary stenosis by coronary magnetic resonance angiography[J]. Heart Vessels, 2000, 15(4):159-166.

[1]	李殿富 . 核素显像识别存活心肌的临床应用进展. 国际放射医学核医学杂志, 2003, 27(3): 105-106110.
[2]	孙璐冰 , 阮翘 . 心肌灌注显像联合冠状动脉钙化积分诊断冠心病的价值及最新进展. 国际放射医学核医学杂志, 2017, 41(2): 143-149. doi: 10.3760/cma.j.issn.1673-4114.2017.02.012
[3]	张科 , 谭红霞 , 宋波 . ⁹⁹Tc^m-MIBI心肌灌注显像对行PCI术的冠心病患者中的近期效果的评估作用. 国际放射医学核医学杂志, 2019, 43(5): 422-426. doi: 10.3760/cma.j.issn.1673-4114.2019.05.007
[4]	李胜亭 , 刘秀杰 . 心肌显像估测冠心病预后的价值. 国际放射医学核医学杂志, 1996, 20(1): 4-8.
[5]	李殿富 . 核素心肌显像在冠心病处理决策中的合理应用及其原理. 国际放射医学核医学杂志, 2004, 28(2): 56-59.
[6]	李殿富 . 慢性稳定型冠心病的核素心肌灌注显像临床应用进展. 国际放射医学核医学杂志, 2004, 28(3): 97-100.
[7]	郭小闪 , 靳春荣 , 武志芳 , 武萍 , 李莉 , 陈伟强 , 李思进 . 瑞加诺生负荷心肌灌注显像诊断冠心病的初步临床研究. 国际放射医学核医学杂志, 2020, 44(10): 634-640. doi: 10.3760/cma.j.cn121381-202003048-00088
[8]	张建萍 , 刘雪辉 , 于泓煦 , 刘娜 , 沈慧 , 陈兵 . 心肌灌注显像引导下行PCI治疗的Graves甲亢合并冠心病一例. 国际放射医学核医学杂志, 2019, 43(6): 589-592. doi: 10.3760/cma.j.issn.1673-4114.2019.06.016
[9]	彭琨 , 陈卫强 , 李剑明 . 冠状动脉血流储备分数、心肌血流储备和微循环阻力指数在冠心病患者中的临床应用价值. 国际放射医学核医学杂志, 2019, 43(5): 462-467. doi: 10.3760/cma.j.issn.1673-4114.2019.05.014
[10]	黄钢 , 赵惠杨 . PET心肌代谢显像评价心肌梗塞区存活心肌. 国际放射医学核医学杂志, 1995, 19(6): 241-244.

点击查看大图

计量

文章访问数: 1167
HTML全文浏览量: 134
PDF下载量: 2

核素心肌显像在冠状动脉旁路移植术中的应用

张佳胤

200025 上海, 上海第二医科大学瑞金医院核医学科

收稿日期: 2004-11-24

关键词:

摘要: 心肌存活的判断对于严重冠心病患者选择再血管化适应证、估测疗效和判断预后有着极其重要的临床意义。传统的²⁰¹Tl静息-再分布显像能较好又经济地评估心肌活力,门控显像技术显示的室壁运动情况能帮助医师更准确地判断缺血心肌的活力,¹⁸F-氟代脱氧葡萄糖(¹⁸F-FDG)心肌代谢显像是迄今评估心肌活力最准确的方法。患者在冠状动脉旁路移植术后出现胸闷症状时,核素心肌显像也能准确地判断有无新发缺血灶或是原有病变术后再狭窄。